Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
超越數字：11位分析師討論塞德斯醫療股票
A comprehensive...In the preceding three months, 11 analysts have released ratings for Celldex Therapeutics (NASDAQ:CLDX), presenting a wide array of perspectives from bullish to bearish.
在前三個月中，11位分析師已對塞德斯醫療（納斯達克：CLDX）發佈了評級，表現出從看好到看淡的廣泛觀點。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您將找到他們最近的評級摘要，揭示了過去30天內情緒的變化，並將它們與前幾個月進行比較。
In the assessment of 12-month price targets, analysts unveil insights for Celldex Therapeutics, presenting an average target of $68.55, a high estimate of $80.00, and a low estimate of $45.00. This current average has decreased by 3.45% from the previous average price target of $71.00.
在對12個月價格目標的評估中，分析師爲塞德斯醫療揭示了見解，提供了68.55美元的平均目標，80.00美元的高估計和45.00美元的低估計。當前平均水平比之前的71.00美元價格目標下降了3.45%。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級：詳細剖析
A comprehensive...
對財...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間